CURRICULUM VITAE

NAME: DANILO FLISER

Danilo Fliser

DOB 13/04/1962
   
POB Maribor, Slovenia
      
E-mail danilo.fliser@uniklinikum-saarland.de
   
Dr Fliser was born in 1962 in Maribor, Slovenia, and completed his medical studies at the University of Ljubljana, Slovenia. He started his junior academic career in the Division of Nephrology at the Ruperto-Carola University, Heidelberg, Germany, were he was appointed as Assistant Professor of Medicine in 1998. In 1999 he moved to Hannover, and was appointed as Associate Professor of Medicine in the Department of Nephrology at the Hannover Medical School. Since 2007, he is Professor of Medicine and Head of the Department of Internal Medicine IV (Renal & Hypertensive Disease) and of the Transplant Centre at the Saarland University Medical Centre in Homburg, Germany.

His main areas of research are progression of chronic kidney disease, endothelial and vascular biology including endothelial regeneration, and cardiovascular complications in patients with chronic kidney disease, with a strong commitment to translational medicine. Dr Fliser has authored more than 260 original publications (PubMed 1/2015), which are widely cited (current Hirsch Factor: 56). In 2005, he has received the prestigious Franz Volhard Award of the German Society of Nephrology.

Dr Fliser is on the editorial board of renowned national and international nephrology journals, including Der Nephrologe (Managing Editor), Nephrology, Dialysis and Transplantation (Theme Editor Cardiovascular Medicine) and Journal of the American Society of Nephrology. He also serves as a reviewer for major international journals and institutions. Furthermore, in the past years he had many invited presentations at national and international nephrology meetings.

As an active ERA-EDTA member, Dr Fliser participates in various society activities. He was a founding member of the ERA-EDTA European renal and cardiovascular medicine (EURECAM) working group and is currently member of the ERA-EDTA endorsed European Study Group on Uraemia Toxicity (EUTox). He also contributed to the European Renal Best Practice (ERBP) commentary statements. Finally, Dr Fliser was appointed as the Scientific Committee Chair for the 53. Congress of the ERA-EDTA in Vienna 2016.